MIM
GNCA

Monashee Investment Management’s Genocea Biosciences, Inc. GNCA Stock Holding History

Monashee Investment Management’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-100,000
Closed -$392K – 223
2019
Q2 		$392K Buy
+100,000
New +$522K 0.1% 122

Other funds holding GNCA

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.99% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Monashee Investment Management's GNCA Position: Q3 2019 in Review

Monashee Investment Management sold out of Genocea Biosciences, Inc. (GNCA) in Q3 2019, closing a stake of 100,000 shares — an estimated $392K sold.

Monashee Investment Management first reported a position in GNCA in Q2 2019 and held it in 1 quarter. The position peaked at $392K in Q2 2019. 37 funds tracked by Wall St. Rank hold GNCA as of Q3 2019.

  • Monashee Investment Management reported no remaining Genocea Biosciences, Inc. position as of Q3 2019 after selling out during the quarter.
  • Monashee Investment Management sold 100,000 Genocea Biosciences, Inc. shares in Q3 2019, an estimated $392K.
  • Monashee Investment Management first reported a position in Genocea Biosciences, Inc. in Q2 2019 and held it in 1 quarter.
  • Monashee Investment Management's Genocea Biosciences, Inc. position peaked at $392K in Q2 2019.
  • 37 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q3 2019.

Based on Monashee Investment Management's 13F filing for Q3 2019, filed 12 Nov 2019.